"Designing Growth Strategies is in our DNA"

U.S. Immunology Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Monoclonal Antibody (mAb), Fusion Proteins, Immunosuppressants, and Others), By Disease Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Prophylaxis of Organ Rejection, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Country Forecast, 2023-2030

Last Updated: December 15, 2025 | Format: PDF | Report ID: FBI109151

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of the Key Disease Indications, 2022
    2. New Product Launches, Key Players
    3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    4. Impact of Covid-19 on the Market
  5. U.S. Immunology Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Monoclonal Antibody (mAb)
      2. Fusion Proteins
      3. Immunosuppressants
      4. Others
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Rheumatoid Arthritis
      2. Psoriatic Arthritis
      3. Plaque Psoriasis
      4. Ankylosing Spondylitis
      5. Inflammatory Bowel Disease
      6. Prophylaxis of Organ Rejection
      7. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. AbbVie, Inc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Johnson & Johnson Services, Inc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Eli Lilly and Company
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Novartis AG
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Merck Sharp & Dohme Corp.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Pfizer Inc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Astellas Pharma Inc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. UCB SA (Belgium)
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      10. Amgen Inc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      11. Bristol-Myers Squibb Company
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of the Key Disease Indications, 2022
    2. New Product Launches, Key Players
    3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    4. Impact of Covid-19 on the Market
  5. U.S. Immunology Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Monoclonal Antibody (mAb)
      2. Fusion Proteins
      3. Immunosuppressants
      4. Others
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Rheumatoid Arthritis
      2. Psoriatic Arthritis
      3. Plaque Psoriasis
      4. Ankylosing Spondylitis
      5. Inflammatory Bowel Disease
      6. Prophylaxis of Organ Rejection
      7. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. AbbVie, Inc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Johnson & Johnson Services, Inc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Eli Lilly and Company
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Novartis AG
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Merck Sharp & Dohme Corp.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Pfizer Inc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Astellas Pharma Inc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. UCB SA (Belgium)
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      10. Amgen Inc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      11. Bristol-Myers Squibb Company
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Figure 1: U.S. Immunology Market Revenue Breakdown (USD billion, %), By Drug Class, 2022 & 2030

Figure 2: U.S. Immunology Market Value Share (%),By Drug Class, 2022 & 2030

Figure 3: U.S. Immunology Market Value Share (%), By Disease Indication, 2022 & 2030

Figure 4: U.S. Immunology Market Value Share (%), By Distribution Channel, 2022 & 2030

Table 1: U.S. Immunology Market Revenue (USD billion) Forecast, By Drug Class, 2019–2030

Table 2: U.S. Immunology Market Revenue (USD billion) Forecast, By Disease Indication, 2019–2030

Table 3: U.S. Immunology Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2030

U.S. Immunology Market
  • 2019-2030
  • 2022
  • 2019-2021
  • 70
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports